Vård vid hjärtsvikt kan bli bättre

Lakartidningen

Volumn , Issue 25, 1997, Pages 2369-2372

  Rydén, Lars ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

CONGESTIVE HEART FAILURE; COST CONTROL; ECONOMICS; HUMAN; PATIENT COMPLIANCE; REVIEW; SWEDEN;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; COST SAVINGS; HEART FAILURE, CONGESTIVE; HUMANS; PATIENT COMPLIANCE; SWEDEN;

EID: 0031577019     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Remes J, Miettinen H, Reunanan A, Pyörälä K. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991; 12: 315-21.
2. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 1994; 71: 584-7.
3. Dahlström U, Pehrsson K, Pouleur H. Diastolisk dysfunktion vid hjärtsvikt. Fler studier krävs kring diagnos och terapi. Läkartidningen 1995; 92: 1360-3.
4. Lindvall K. Utsikt. Stockholm: HSN-koncernstaben, Stockholms läns landsting, 1994:2.
5. Ghali JK, Kadaki S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med 1988; 148: 2013-6.
6. Monane M, Bohn KL, Gurwitz JH, Glynn RJ, Avorn J. Non compliance with congestive heart failure therapy in the elderly. Arch Intern Med 1994; 154: 433-7.
7. Lindsay HSJ, Hall AS, Morris JL, Zaman AG, Cowan JC. Strategies of ACE-inhibition following myocardial infarction. Costs and benefits. Eur Heart J 1994; 15 suppl: 328.